ICAAC 45th

Title Content type
Dose Response Curves and Dose Fractionation Studies with BAL8557 in a Murine Model of Disseminated Candidiasis (click for details)
Antifungal Activity of BAL4815, a Novel Azole Against Dermatophytes and Emerging Non-Dermatophyte Fungi Including Zygomycetes (click for details)
In vitro activity of the new azole BAL4815 against clinical dermatophyte isolates (click for details)
In Vitro Activity of the New Azole BAL4815 against Clinical Candida Isolates Comprising Resistant C. albicans and Less Susceptible Candida spp (click for details)
Efficacy, Safety, and Tolerability of three Different Dosing Regimens of BAL8557 Vs. Fluconazole in a Double-Blind, Randomized, Multicenter Trial for the Treatment of Esophageal Candidiasis in Immunocompromised Adults (click for details)
In vivo Efficacy of the triazole BAL8557 (BAL) Compared to Voriconazole (VOR), Itraconazole (ITC) and Caspofungin (CAS) By a New qPCR and Quantitative Culture in a Neutropenic Murine Model of Aspergillus flavus (click for details)
Characterization of Galactomannan (GM) EIA and Quantitative Real-Time PCR (qPCR) for the Detection of Aspergillus fumigatus from Bronchoalveolar Lavage (BAL) Fluid in Experimental Invasive Pulmonary Aspergillosis (IPA) (click for details)
Combination Therapy of Micafungin (MIC) and Amphotericin B (AMB) in Experimental Invasive Pulmonary Aspergillosis (IPA) in Dexamethasone (DEXA) Treated Rats (click for details)
Incidence of Breakthrough Invasive Fungal Infections with Non-Albicans Candida Species and Zygomycetes after Prophylaxis with Itraconazole: Data from a Meta-Analysis (click for details)
Micafungin (MICA) in Combination with Voriconazole (VRC) in Aspergillus Species: a Pharmacodynamic Approach for Detection of Synergy In Vitro (click for details)

Pages

Subscribe to ICAAC 45th